Express Scripts Reaches New 52-Week High (ESRX)

NEW YORK ( TheStreet) -- Express Scripts (Nasdaq: ESRX) hit a new 52-week high Wednesday as it is currently trading at $66.10, above its previous 52-week high of $66.06 with 2.4 million shares traded as of 12:46 p.m. ET. Average volume has been 4.6 million shares over the past 30 days.

Express Scripts has a market cap of $53.16 billion and is part of the health care sector and health services industry. Shares are up 20.2% year to date as of the close of trading on Tuesday.

Express Scripts Holding Company provides a range of pharmacy benefit management (PBM) services primarily in the United States and Canada. It offers healthcare management and administration services on behalf of its clients.

  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

TheStreet Ratings rates Express Scripts as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, compelling growth in net income, good cash flow from operations, largely solid financial position with reasonable debt levels by most measures and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. You can view the full Express Scripts Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more..
null

If you liked this article you might like

The Dow Binges on Earnings

Alphabet Slides After a So-So Quarter - 5 Things You Must Know Before the Market Opens